SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study.

Conte, G; Bergonti, M; Probst, V; Morita, H; Tfelt-Hansen, J; Behr, ER; Kengo, K; Arbelo, E; Crotti, L; Sarquella-Brugada, G; et al. Conte, G; Bergonti, M; Probst, V; Morita, H; Tfelt-Hansen, J; Behr, ER; Kengo, K; Arbelo, E; Crotti, L; Sarquella-Brugada, G; Wilde, AAM; Calò, L; Sarkozy, A; de Asmundis, C; Mellor, G; Migliore, F; Letsas, K; Vicentini, A; Levinstein, M; Berne, P; Chen, S-A; Veltmann, C; Biernacka, EK; Carvalho, P; Kabawata, M; Sojema, K; Gonzalez, MC; Tse, G; Thollet, A; Svane, J; Caputo, ML; Scrocco, C; Kamakura, T; Pardo, LF; Lee, S; Juárez, CK; Martino, A; Lo, L-W; Monaco, C; Reyes-Quintero, ÁE; Martini, N; Oezkartal, T; Klersy, C; Brugada, J; Schwartz, PJ; Brugada, P; Belhassen, B; Auricchio, A (2024) aTrial arrhythmias in inhEriTed aRrhythmIa Syndromes: results from the TETRIS study. Europace, 26 (12). euae288. ISSN 1532-2092 https://doi.org/10.1093/europace/euae288
SGUL Authors: Behr, Elijah Raphael

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (542kB) | Preview
[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution Non-commercial.

Download (810kB) | Preview

Abstract

BACKGROUND: Little is known about the distribution and clinical course of patients with inherited arrhythmia syndrome (IAS) and concomitant atrial arrhythmias (AAs). AIM: 1) to characterize the distribution of AAs in patients with IAS and 2) evaluate the long-term clinical course of these patients. METHODS: An international multicenter study was performed and involved 28 centers in 16 countries. Inclusion criteria were: 1) IAS and 2) ECG documentation of AAs. The primary endpoint was a composite of sudden cardiac death, sustained VAs or appropriate ICD interventions. Strokes, inappropriate ICD shocks due to AAs, and the occurrence of sinus node dysfunction were assessed. RESULTS: A total of 522 patients with IAS and AAs were included. Most patients were diagnosed with Brugada syndrome (n=355, 68%) and long-QT syndrome (n=93, 18%). The remaining patients (n=71, 14%) presented with short-QT syndrome, early repolarization syndrome (ERS), catecholaminergic polymorphic ventricular tachycardia (CPVT), progressive cardiac conduction diseases, or idiopathic ventricular fibrillation. Atrial fibrillation (AF) was the most prevalent AA (82%), followed by atrial flutter (9%) and atrial tachycardia (9%). AA was the first clinical manifestation of IAS in 52% of patients. More than one type of AAs was documented in 23% of patients. Nine patients (3%) experienced VA before the diagnosis of IAS, due the use of anti-arrhythmic medications taken for the AA. The incidence of the primary endpoint was 1.4% per year, with a twofold increase observed in patients who experienced their first AA before the age of 20 (OR 2.2, p=0.043). This was consistent across the different forms of IAS. Inappropriate ICD shock due to AAs were reported in 2.8% of patients, strokes in 4.4% and sinus node dysfunction in 9.6%. CONCLUSIONS: Among patients with IAS and AAs, AA is the first clinical manifestation in about half of the cases, with more than one form of AAs present in one-fourth of the patients. The occurrence of AA earlier in life may be associated with a higher risk of ventricular arrhythmias. The occurrence of stroke and sinus node dysfunction is not-infrequently in this cohort.

Item Type: Article
Additional Information: © The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.
Keywords: Brugada syndrome, atrial arrhythmias, atrial fibrillation, channelopathies, inherited arrhythmias syndrome, long QT syndrome, sudden cardiac death, ventricular arrhythmias, atrial arrhythmias, atrial fibrillation, Brugada syndrome, channelopathies, inherited arrhythmias syndrome, long QT syndrome, sudden cardiac death, ventricular arrhythmias, 1103 Clinical Sciences, Cardiovascular System & Hematology
SGUL Research Institute / Research Centre: Academic Structure > Cardiovascular & Genomics Research Institute
Academic Structure > Cardiovascular & Genomics Research Institute > Clinical Cardiology
Journal or Publication Title: Europace
ISSN: 1532-2092
Language: eng
Dates:
DateEvent
December 2024Published
11 November 2024Published Online
10 November 2024Accepted
Publisher License: Creative Commons: Attribution-Noncommercial 4.0
Projects:
Project IDFunderFunder ID
PZ00P3_180055Swiss National Science Foundationhttp://dx.doi.org/10.13039/501100001711
PubMed ID: 39527076
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116961
Publisher's version: https://doi.org/10.1093/europace/euae288

Actions (login required)

Edit Item Edit Item